The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1086/504379 | DOI Listing |
Publication Analysis
Top Keywords
rhabdomyolysis therapy
8
therapy daptomycin
8
daptomycin
4
daptomycin daptomycin
4
daptomycin associated
4
associated elevation
4
elevation creatine
4
creatine phosphokinase
4
phosphokinase level
4
level reported
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!